Loading clinical trials...
Loading clinical trials...
High Flow Nasal Oxygen for Acute Hypoxemic Respiratory Failure in the Emergency Room: the GLAMOUR Study
The aim of this multicenter, randomized, controlled, open-label trial is to investigate the efficacy of early treatment with HFNO compared with SOT in preventing early deterioration of patients admitted to the ER because of acute hypoxemic respiratory failure.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
July 1, 2024
Primary Completion Date
July 1, 2025
Completion Date
July 1, 2026
Last Updated
July 5, 2024
234
ESTIMATED participants
high flow nasal cannula
DEVICE
standard oxygen
OTHER
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT02273687
NCT01743105
NCT05081895
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions